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Abstract  13 
Objective 14 
To determine whether patients undergoing therapeutic hypothermia following cardiac 15 
arrest tolerate early enteral nutrition. 16 
  17 
Methods 18 
We undertook a single-centre longitudinal cohort analysis of the tolerance of enteral 19 
feeding by 55 patients treated with therapeutic hypothermia following resuscitation 20 
from cardiac arrest. The observation period was divided into three phases: (1) 24 h 21 
at target temperature (32-34°C); (2) 24 h rewarming to 36.5°C; and (3) 24 h 22 
maintained at a core temperature below 37.5°C.  23 
Results 24 
During period 1, patients tolerated a median of 72% (interquartile range (IQR) 25 
68.7%; range 31.3 to 100%) of administered feed. During period 2 (rewarming 26 
phase), a median of 95% (IQR 66.2%; range 33.77 to 100%) of administered feed 27 
was tolerated. During period 3 (normothermia) a median of 100% (IQR 4.75%; range 28 
95.25 to 100%) of administered feed was tolerated. The highest incidence of 29 
vomiting or regurgitation of feed (19% of patients) occurred between 24-48 h of 30 
therapy. 31 
Conclusions 32 
Patients undergoing therapeutic hypothermia following cardiac arrest may be able to 33 
tolerate a substantial proportion of their daily nutritional requirements. It is possible 34 
that routine use of prokinetic drugs during this period may increase the success of 35 
feed delivery enterally and this could usefully be explored. 36 
 37 
38 
Introduction 39 
Clinical guidelines issued by the National Institute for Health and Care Excellence 40 
(NICE) identify critically ill patients as at risk of malnutrition attributable to inadequate 41 
oral intake, poor gastrointestinal absorption or increased nutritional requirements due 42 
to catabolism.1 To meet energy requirements, a baseline of 25-30 kcal/kg enteral 43 
feed is advised. Early enteral feeding has been advocated to prevent malnutrition in 44 
hypercatabolic states.2  Further benefits include enhanced wound healing, reduced 45 
incidence of infection, and maintenance and function of the gastrointestinal tract 46 
including the reduction of organism translocation.2,3,4,5  Timely provision of nutrition is 47 
therefore a routine component of care; however, recommendations for patients 48 
undergoing therapeutic hypothermia (TH) are less clear. 49 
 50 
Some authors advise that nutrition should not be provided during TH, including the 51 
induction, maintenance or re-warming phase of the therapy,6,7 while others imply that 52 
nutrition can be provided but at reduced volume, which reflects the reduced demand 53 
associated with the low basal metabolic rate induced by hypothermia.8 54 
 55 
An ischaemic injury initiates a cascade of free radicals on reperfusion, which can 56 
exacerbate tissue injury.9 During cardiac arrest severe intestinal ischaemia occurs 57 
causing translocation of bacteria and endotoxins10,11 and early intestinal dysfunction 58 
ensues.12  Critical illness and hypothermia are reported to delay gastric emptying 59 
and decrease peristalsis causing ileus/stasis;9,13,14  both contributing to intolerance of 60 
enteral feed. Reports state the incidence of ileus in critical illness to be between 50-61 
80%,15 delayed gastric emptying to occur in 70% of mechanically ventilated 62 
patients16 and gut dysfunction in 60% of patients after out-of-hospital cardiac 63 
arrest.17 However, there are no published data addressing the tolerance of enteral 64 
feed by patients undergoing TH after cardiac arrest. 65 
 66 
On our intensive care unit (ICU), we routinely attempt early enteral feeding in 67 
patients undergoing TH. This descriptive study therefore set out to examine whether 68 
early enteral nutrition is tolerated by hypothermic patients following cardiac arrest. 69 
 70 
Methods  71 
The hospital’s research and development department granted retrospective access 72 
to nursing notes and electronic Intensive Care National Audit and Research Centre 73 
(ICNARC) records. As this study is a form of service evaluation, patient care was not 74 
altered (or alterable) in any way and all data was anonymous, ethical approval was 75 
not required.  76 
 77 
The study took place in a single mixed ICU in a district general hospital with 78 
considerable experience and stable protocols for the management of TH in patients 79 
following cardiac arrest. Potential participants were identified using the local dataset 80 
of the ICNARC database and included patients admitted to the Royal United 81 
Hospital, Bath ICU between April 2006 and December 2010. 82 
 83 
Exclusions preventing TH include pre-existing coagulopathy or internal bleeding, 84 
pregnancy, established multi organ failure, and severe systemic infection.  These 85 
have been established criteria since cooling was introduced in 2002.  Both the 86 
management of TH and of enteral nutrition are performed according to local 87 
protocols. All patients were sedated with propofol (1-3 mg kg-1 h-1) and alfentanil (10 88 
– 50 mcg kg-1 h-1) until return to normothermia. Hypothermia was induced and 89 
maintained with the Alsius Coolgard 3000 (Zoll Medical Corporation, Massachusetts, 90 
USA) and an indwelling femoral cooling catheter. Core temperature was recorded 91 
using a Tyco Thermistor 400 series (Tyco Healthcare, California, USA) bladder 92 
catheter (integrally connected and continuously displayed via the Coolgard). Enteral 93 
feed was delivered via a Nutricia Flocare Infinity (Nutricia Ltd, Trowbridge, Wiltshire, 94 
UK) continuous feeding pump.  All patients received Nutricia Nutrison standard feed 95 
formula of 1Kcal/ml (Nutricia Ltd, Trowbridge, Wiltshire, UK). 96 
 97 
The therapeutic hypothermia process can be divided into three distinct phases: (1) 98 
24 h at target temperature (32-34°C); (2) 24 h rewarming to 36.5°C; and (3) 24 h 99 
maintained at a core temperature below 37.5°C.  100 
  101 
 102 
The local ICNARC data set was searched to identify patients admitted to the ICU 103 
who had a core temperature of 34°C or less, a Glasgow Coma Score (GCS) of less 104 
than 8, and a record of cardiopulmonary resuscitation (CPR).  This search identified 105 
120 patients.  Further checks were performed to exclude any patients who did not 106 
undergo TH, or who did not complete a 72 h period of TH as described above. 55 107 
patients were identified.     108 
 109 
Demographic details were extracted from the local ICNARC dataset: age, gender, 110 
admission date, in hospital (IH) or out of hospital (OOH) cardiac arrest, and Acute 111 
Physiology and Chronic Health Evaluation II (APACHE II) score. The APACHE II 112 
score reflects the severity of acute physiological disturbance and chronic disease on 113 
admission.18 Data on enteral feeding, (timing, success or failure, vomiting events or 114 
increased gastric aspirate volumes) and body temperature was retrieved from 115 
nursing observation charts, forming an essential legal record of ICU care and patient 116 
status. Complete records were therefore anticipated though accuracy may not be 117 
guaranteed.   118 
 119 
Data extraction for the purposes of the study commenced when the patient reached 120 
the target temperature of 32 to 34°C. The total volume of feed administered and 121 
volume of gastric aspirates during the three phases of the hypothermic therapy was 122 
extracted. The duration for data collection on each patient was 72 h.  Any incidences 123 
of vomiting or regurgitation were also noted as a further sign of gastric intolerance. 124 
 125 
 126 
The volume of enteral feed delivered was recorded as the volume administered 127 
enterally after subtracting the volume of any discarded aspirate (returned aspirate 128 
was discounted).  This was then converted to a percentage of delivered feed.  Some 129 
patients had large gastric aspirates that exceeded the volume of enteral feed 130 
administered resulting in a negative administration data. It was deemed necessary to 131 
include these negative data as it could not be determined whether aspirates were 132 
feed or bile or a mixture.  The volume of feed tolerated (successfully delivered 133 
enterally) during each of the three phases of hypothermia was recorded.  Failure to 134 
tolerate feed was deemed to have occurred if the volume of gastric aspirates 135 
exceeded the volume delivered or if the patient vomited. 136 
 137 
Statistical analysis was performed using the Statistical Package for the Social 138 
Sciences (SPSS) version 19. Correlations between absorption of feed and APACHE 139 
II scores, age and gender were explored using a Spearman Rank test.  140 
 141 
Results 142 
The sample consisted of 55 patients between the ages of 20-85 years (median 68). 143 
The median APACHE II score was 18 (range from 12 – 34). There were 35 males 144 
and 20 females. One patient was not fed for the entire 72 h period being studied and 145 
feeding was not attempted for at least one day in a further eight.  Data have been 146 
presented for all patients for whom these were available for each 24 hour period 147 
(Table 1 and Figure 1). All patients were fed nasogastrically. There was no 148 
correlation between volume of feed tolerated and APACHE II scores (r = 0.052; P 149 
=0.708), age (r = 0.005; P =0.972), and gender (r = 0.004; P =0.979). 150 
 151 
During phase one (cooling), 43 (83%) patients tolerated some feed and nine (13%) 152 
had net negative gastric aspirates (aspirate volumes exceeding the volume of 153 
administered feed by 25% to 327%). During phase 2 (rewarming), 43 (83%) patients 154 
tolerated some feed and nine (13%) had net negative gastric aspirates. During 155 
phase 3 (normothermia), 43 (91%) patients tolerated almost all administered feed 156 
and four (9%) had net negative gastric aspirates (aspirate volumes exceeding the 157 
volume of administered feed by 10% to 204%).  158 
 159 
Discussion  160 
Our study shows that more than 80% of patients tolerate at least some enteral feed 161 
during all three phases of TH; however, several patients (nine on day 1, nine on day 162 
two and four on day 3) produced a volume of discarded gastric aspirates that 163 
exceeded nutritional input.  164 
 165 
At core temperatures of 32-34°C, patients tolerated a median of 72% of administered 166 
enteral feed which represents median feed volumes of 243 ml per 24 h or 167 
approximately 10 ml/h. Standard enteral feeds provide 1 kcal/ml energy.  An average 168 
75 kg male would require 1875 ml of feed per 24 h; 240 ml would account for 169 
approximately 12% of normal daily energy requirements.  During the cool phase, five 170 
patients vomited/regurgitated while almost a fifth of patients produced gastric 171 
aspirates that exceeded nasogastric input.  These findings suggest a significant 172 
number of patients in this phase have gastric stasis and are intolerant of enteral 173 
feeding.  174 
 175 
During the rewarming phase from 24-48 h, the patients were rewarmed at 0.25°C/h 176 
meaning that patients would have had a core temperature below 36°C for at least 10 177 
h of this phase.  During this phase, most patients tolerated almost all of their feed 178 
(median 95%) but vomiting/regurgitation occurred in 19% and almost one fifth of 179 
patients still had high gastric aspirate volumes. Prokinetics were generally not given 180 
during phase 1 or 2 of therapy (0-48 h) as this was not usual practice.  181 
 182 
Underfeeding limits the outcome benefits of early enteral feeding. Although our staff 183 
usually follow a feeding protocol, this was seldom followed for patients undergoing 184 
TH. Components of the protocol including the regularity of checking gastric residual 185 
volumes and incremental increases in feed rate to an individualised, weight-related 186 
maximum dose were practised inconsistently. Many nursing staff provided nutrition 187 
at a reduced rate (10-30 ml/h) while few appropriately increased the rate (by 30 ml 188 
increments) when aspirates were minimal (<200 ml every 4 h). 189 
   190 
Most patients tolerated a high proportion of the feed that was administered; many of 191 
these may have been able to tolerate a higher volume but because the feeding 192 
protocol was often not followed, we were unable to evaluate this reliably. Forty 193 
percent of our cohort had gastric aspirates that exceeded delivered nutrition on one 194 
or more days of the study period.  A high incidence of ileus or delayed gastric 195 
emptying is well documented in the critically ill and targets for enteral nutrition are 196 
frequently not achieved.15,16,17   197 
 198 
In the presence of gastric stasis, post-pyloric feeding may enable successful delivery 199 
of enteral feed19 and this strategy might usefully be studied in post cardiac arrest 200 
patients. The routine use of prokinetics throughout TH may increase the tolerance of 201 
enteral feed.  202 
  203 
A separate feeding protocol for post cardiac arrest patients undergoing TH, would 204 
provide clear instruction and a rationale for reduced rates of feeding, as well as how 205 
to assess the success of enteral feeding in this group. 206 
 207 
Strengths and limitations  208 
This is first study to specifically examine the possibility of feeding hypothermic 209 
patients post arrest.  We included a reasonable sample size, which represented the 210 
post cardiac arrest patients that were cooled in our ICU over a 4-year period and 211 
survived at least 3 days. Only two patients’ records could not be located and 212 
considered for inclusion.  All other records were complete. 213 
 214 
Our data reflect the feeding practices of only one ICU and was collected 215 
retrospectively. The study is descriptive, preventing any control of feeding practices. 216 
Although we documented the volume of feed delivered successfully (tolerated), we 217 
have no way of knowing whether this feed was actually absorbed from the small 218 
bowel. The ratio of feed to endogenous secretions was impossible to determine and 219 
by assuming that all discarded aspirate was feed it is likely that our data 220 
underestimate the degree of absorption. We have no data on confounders such as 221 
past medical history (especially related to gastrointestinal disorders) or the technique 222 
used when aspirating gastric contents.  The use of alfentanil for sedation is also 223 
likely to have reduced the tolerance to enteral feeding. Our sample size was too 224 
small to enable any useful study of survival.  225 
 226 
Prospective studies are required to assess the value of enteral feeding during TH.  227 
Earlier, routine use of prokinetics may improve the tolerance of larger volumes of 228 
feed but this requires evaluation prospectively. Ultimately, there is a need to 229 
understand the metabolic requirements of cooled patients so that delivery of nutrition 230 
can be optimised. 231 
 232 
Conclusion 233 
Most post cardiac arrest patients treated with TH tolerate at least a proportion of 234 
administered enteral feed. Feed is progressively better tolerated as patients are 235 
rewarmed. A reduced rate of feed should be considered when patients are at the 236 
target temperature of 32-34°C. The feed rate can be incrementally increased once 237 
the patient’s temperature has increased to normothermia.  238 
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Legend 247 
Figure 1. Median volumes (mL) of feed administered and tolerated in each 24 h 248 
period. 249 
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